True North Advisors LLC Has $908,000 Stock Position in U.S. Physical Therapy, Inc. $USPH

True North Advisors LLC increased its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 17.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,615 shares of the company’s stock after buying an additional 1,714 shares during the quarter. True North Advisors LLC owned about 0.08% of U.S. Physical Therapy worth $908,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Portside Wealth Group LLC raised its stake in shares of U.S. Physical Therapy by 3.9% in the first quarter. Portside Wealth Group LLC now owns 4,108 shares of the company’s stock worth $297,000 after purchasing an additional 154 shares during the last quarter. Precision Wealth Strategies LLC raised its stake in shares of U.S. Physical Therapy by 6.6% in the first quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company’s stock worth $221,000 after purchasing an additional 189 shares during the last quarter. Bessemer Group Inc. raised its stake in shares of U.S. Physical Therapy by 4.4% in the first quarter. Bessemer Group Inc. now owns 4,929 shares of the company’s stock worth $357,000 after purchasing an additional 208 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of U.S. Physical Therapy by 90.6% in the second quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock worth $35,000 after purchasing an additional 213 shares during the last quarter. Finally, Comerica Bank raised its stake in shares of U.S. Physical Therapy by 3.0% in the first quarter. Comerica Bank now owns 8,181 shares of the company’s stock worth $592,000 after purchasing an additional 237 shares during the last quarter.

Analysts Set New Price Targets

USPH has been the subject of several analyst reports. JPMorgan Chase & Co. initiated coverage on U.S. Physical Therapy in a research note on Thursday, September 18th. They issued an “overweight” rating and a $110.00 price objective for the company. Barrington Research increased their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a research report on Friday, August 8th. Zacks Research raised U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. Finally, Wall Street Zen downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Sunday, September 21st. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, U.S. Physical Therapy presently has an average rating of “Moderate Buy” and an average price target of $110.25.

U.S. Physical Therapy Stock Performance

USPH stock opened at $82.53 on Friday. The stock has a market capitalization of $1.25 billion, a PE ratio of 36.04, a price-to-earnings-growth ratio of 4.10 and a beta of 1.47. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $101.19. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The stock’s 50 day simple moving average is $80.76 and its 200 day simple moving average is $76.47.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.10. The business had revenue of $197.34 million for the quarter, compared to analysts’ expectations of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The firm’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.73 EPS. As a group, research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were given a $0.45 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 annualized dividend and a yield of 2.2%. U.S. Physical Therapy’s dividend payout ratio is 78.60%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,792 shares of the business’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $86.57, for a total transaction of $155,133.44. Following the completion of the sale, the chief operating officer directly owned 22,246 shares in the company, valued at approximately $1,925,836.22. The trade was a 7.45% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Christopher J. Reading sold 2,000 shares of the business’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $83.53, for a total transaction of $167,060.00. Following the sale, the chief executive officer owned 114,088 shares of the company’s stock, valued at approximately $9,529,770.64. This represents a 1.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,853 shares of company stock worth $581,406 in the last three months. Corporate insiders own 2.00% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.